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During the past decade, UNLV’s Schools of Allied Health 
Sciences and Nursing have expanded their research 
programs and boosted collaboration among faculty 
investigators in support of the university’s vision of 
becoming a major research institution.
In Allied Health Sciences, these projects include a range 
of potentially patient-benefitting areas, among them 
investigations in health physics and diagnostic sciences, 
physical therapy, nutrition, and kinesiology.  Nursing 
researchers are also working to improve human health 
and wellness, most prominently via projects aimed at 
advancing understanding of issues related to chronic 
conditions such as diabetes, obesity, and stress. Both 
schools will benefit from a recent $20 million grant from 
NIH to support clinical and bench-to-bedside research and 
to lead a health research group, the Clinical Translational 
Research Infrastructure Network, or CTR-IN, comprising 13 
universities across the Mountain West region.  
The following profiles demonstrate the diversity and 
depth of the two schools’ research projects.
RESEARCH  AS REMEDY
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YU KUANG, AN ASSISTANT PROFESSOR 
in the School of Allied Health Sciences, is fo-
cused on the early detection of cancer and im-
age-guided cancer treatment. His recent work 
explores whether testing for genetic markers 
associated with tumors, coupled with new ap-
proaches to quantitative magnetic resource 
imaging (MRI) analysis, might lead to more 
effective treatments for sarcomas, malignant 
tumors that form in bone, cartilage, fat, mus-
cle, or vascular tissue.
Patients diagnosed with sarcoma usually 
undergo what health care providers call “neo-
adjuvant” therapy — typically chemotherapy 
— to shrink their tumors before surgery. 
Reducing tumor size prior to operating, on-
cologists have found, not only makes surgery 
more effective but also enhances patients’ 
long-term survival rates.
A drawback of this approach is that de-
termining whether neoadjuvant therapy has 
done its job can only happen via tumor-tissue 
analysis following surgery. This means that 
patients don’t learn if they’ve benefitted un-
til after leaving the operating room, an un-
fortunate reality that ensures some patients 
will endure the toxic effects of chemotherapy 
without any therapeutic advantage. For these 
patients, the harm in superfluous chemo is 
not just in the unnecessary discomfort it in-
flicts. Precious time has been wasted — time 
that could have been spent on potentially life-
saving treatment alternatives.
Kuang has teamed up with the Children’s 
Specialty Center of Nevada and Nevada Im-
aging Centers to develop an earlier, non-inva-
sive method for predicting success or failure 
of neoadjuvant chemotherapy. His method in-
volves combining an analysis of tumor mark-
ers in mitochondrial DNA from blood draws 
and diffusion MRI data. The goal, Kuang says, 
is to identify the early changes of genetic bio-
marker levels in the blood and the imaging 
features in the MRI scan that can help clini-
cians more effectively ascertain how well sar-
comas have responded to pre-operative che-
motherapy.  
By determining patients’ response to the 
treatment early in the course of chemother-
apy, Kuang’s team expects this research will 
ultimately enable oncologists to optimize 
treatment protocols for individual patients, 
improving quality of life and enhancing dis-
ease-free survival for patients with sarcoma.
If successful, Kuang’s next step will likely 
involve multi-institutional clinical trials. 
These will seek to determine how this com-
bined biological- and imaging-biomarker 
method might be used to guide future che-
motherapy treatments.
Kuang is also actively involved in multi-
institutional collaborative work related to 
prostate cancer. Earlier this year, he teamed 
up with Sandi A. Kwee, a physician and as-
sociate professor at the John A. Burns School 
of Medicine at the University of Hawaii, to de-
velop a positron emission tomography (PET) 
image guided prostate cancer radiation thera-
py method. PET scan is an imaging test that 
helps reveal how patients’ tissues and organs 
are functioning via a radioactive drug (radio-
tracer). In this collaboration, the  radiotracer 
Kuang and Kwee are using is a new U.S. Food 
and Drug Administration-approved investiga-
tional drug that could allow for better target-
ing of radiation treatments used against inter-
mediate- and high-risk prostate cancer.
The collaborative relationship is expected 
to lead to a multicenter clinical trial initiative 
between UNLV and University of Hawaii, a 
trial that could bring this potentially game-
changing approach to prostate cancer pa-
tients in Southern Nevada.
Yu Kuang: 
Dangerous Tumors,  
Expedited 
Assessments
ACCELERATED ANSWERS A diagnostic tool developed in part by UNLV’s Yu Kuang promises to speed physicians’ 
ability to assess the effectiveness of neoadjuvant therapy in sarcoma patients. If successful, the approach could 
lead to new, more effective ways to combat these potentially deadly malignancies.
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OSTEOARTHRITIS OF THE KNEE, AN IN-
creasingly common health problem among 
active adults, is a painful condition involv-
ing loss of cartilage and deformity of the 
joint. It is also a major factor in diminished 
mobility, especially among older people.
Multiple studies have identified stress in-
juries to the leg bones as a primary contribu-
tor to arthritic knee pain and deformity. Lit-
tle is known, however, about the causes and 
progression of bone-stress injuries among 
middle-aged, active adults.
Kai-Yu Ho, an assistant professor in the 
School of Allied Health Sciences, is directing 
a study that could remedy this deficiency, 
while at the same time providing a method 
for evaluating the probability that osteo-
arthritis is present. She also hopes to help 
doctors detect the sort of bone damage that 
produces osteoarthritis, even before a person 
experiences pain.
Ho’s study involves an examination of 
how “locomotion-induced shock loading” — 
the results of such everyday, bone-jarring 
movement like walking, running, and stair 
climbing — affects the physiology of knees. 
Her work also examines the alignment of 
bones in legs that have stress injuries, and 
how injury-related alignment issues might 
relate to arthritis development.
A normal femur, or upper leg bone, is not 
perfectly vertical. The bone extends from the 
hip at a slight angle toward the midline of 
the body. Normal physical activity can cause 
micro-damage to the femur and tibia where 
they meet at the knee. The body repairs the 
damage by growing new bone, a process 
called bone remodeling.
Continual shock-loading damage can 
cause too much bone remodeling, however, 
with new bone forcing the femur away from 
the midline of the body into a “varus angle” 
(a phrase adapted from the Latin word for 
“crooked”). When the varus angle is pro-
nounced a person appears bowlegged — the 
knees do not touch when one stands with his 
or her feet together.
Ho hypothesizes that increased shock 
loading among middle-aged persons will 
lead to greater bone stress, which can in-
crease the onset of osteoarthritis in the joint. 
She put her hypothesis to the test in a study 
involving 20 adults ranging in age from 50 
to 65. None of her subjects had been diag-
nosed with arthritis in the knee.
Participants were asked to complete a 
locomotion-induced, shock-loading activity. 
When finished, they receive a magnetic res-
onance imaging (MRI) scan to verify bone 
stress injuries. Participants next allowed the 
researchers to measure the angle between 
the long axis of their femurs and tibias.
Ho says she and her team are now analyz-
ing the data they’ve collected to determine 
whether there is an association between low-
er extremity alignment and MRI-detected 
bone stress injury. If there is, she says, the 
finding could provide health-care providers 
with an early detection method of bone ab-
normalities. This, in turn, will enable them 
to recommend physical therapy intervention 
to ward off future bone-stress injuries to pa-
tients’ knees.
Research related to this study has been 
published in the European Journal of Sports 
Science and Magnetic Resonance Imaging.
Kai-Yu Ho: Assessing 
“Shock-Loading” and 
Arthritis Risks
SHOCK AND STRESS  The human knee 
takes a continual pounding, a process 
scientists such as UNLV’s Kai-Yu Ho 
describe as “shock loading.”  Ho’s 
latest research aims to identify how 
shock-loading stress on knees may be 
contributing to arthritis-inducing bone 
alignment issues.
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Barbara St. Pierre 
Schneider: Enhanced 
Care After Extreme 
Compressions
EARTHQUAKES, EXPLOSIONS, INDUSTRIAL 
accidents, car crashes — each are forms of 
mayhem that leave crushing trauma in their 
wake. Barbara St. Pierre Schneider, an asso-
ciate professor in the School of Nursing, is 
working to better understand the biological 
processes characterizing such “skeletal and 
muscle-crush injuries,” and how they might 
best be treated. She is especially concerned 
with U.S. service personnel who have been 
injured on the battlefield.
Whether these injuries occur in military 
combat, during a terrorist attack, or in a natu-
ral disaster, crush-related injuries involve sig-
nificant compression, a traumatic event that 
interrupts blood flow and damages the cell 
membrane of muscle fibers. Although the in-
jury itself may not be immediately life threat-
ening, damaged muscle can increase the risk 
for death down the road: In many cases rup-
tured muscles spill cellular contents, such as 
the muscle protein myoglobin, into the blood-
stream. Myoglobin, for example, can cause 
kidney damage and failure.
Soldiers who experience skeletal muscle-
crush injuries during combat face additional 
challenges. Often, the wounded must endure 
long flights to treatment centers. While un-
avoidable, these evacuations by air expose the 
wounded to hypobaria, a situation in which 
tissues may be deprived of sufficient oxygen, 
which can become a factor when the air pres-
sure is equivalent to an altitude of 8,000 feet, 
or that of a typical plane’s cabin pressure. 
St. Pierre Schneider and her team are study-
ing how hypobaric hypoxia affects the healing 
of injuries and are searching for potential treat-
ments that counteract its effects. A previous St. 
Pierre Schneider study, for example, simulated 
the effects of air transport and examined the 
effect of hypobaric hypoxia on genes within 
skeletal muscle. One major finding was that the 
simulated flights affected the genes affiliated 
with skin integrity, but had no apparent effect 
on inflammatory genes in skeletal muscle. 
To further her hyperbaric hypoxia crush-
muscle research, St. Pierre Schneider is ex-
panding the capabilities of her lab. She re-
cently received grant funding to purchase 
a combined cell sorter/flow cytometer, an 
instrument that allows scientists to measure 
and analyze the inner workings of cells. Hav-
ing the instrument, says St. Pierre Schneider, 
will enhance UNLV’s research capacity and 
the university’s science, technology, engineer-
ing, and mathematics (STEM) program.
St. Pierre Schneider’s studies in muscle in-
jury recovery are guiding techniques in aero-
medical evacuation, and her work has been 
featured in multiple publications, including 
Aviation, Space and Environmental Medicine 
and Innate Immunity.
INJURY AND OXYGEN When soldiers and others 
experience “crush injuries,” their treatment often 
includes evacuation by air. UNLV’s Barbara St. Pierre 
Schneider is exploring why the cabin pressure during 
such flights may be harmful and what to do about it.
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WHEN IT COMES TO PAINFUL CONDITIONS 
affecting the mobility of millions of Ameri-
cans, bum knees take a back seat to bad backs. 
Chronic low-back pain is the most common 
health complaint in the United States, afflict-
ing nearly 30 percent of people older than 
18. In addition to the physical discomfort it 
causes, chronic low-back pain sufferers also 
incur high health care costs. 
In recent years, more physicians and spe-
cialists have recommended self-management 
strategies to help reduce pain, improve qual-
ity of life, and lower associated treatment 
costs. Jennifer Kawi, a chronic pain special-
ist and assistant professor in the School of 
Nursing, is among those who have noted its 
effectiveness, and she is currently working to 
identify those chronic low-back pain sufferers 
who might benefit.
In general, self-management strategies not 
only encourage patients to actively direct and 
improve their health, but they also inspire and 
reinforce patient confidence. Such positive feel-
ings, Kawi says, help patients set realistic goals 
and action plans, and make lifestyle changes 
that often include increased exercise and activ-
ity levels, better eating habits, and greater use 
of non-pharmacological pain remedies such as 
heating wraps and relaxation techniques.
While self-management has improved 
outcomes and lowered health care costs for 
a host of conditions, its effectiveness with 
chronic low-back pain sufferers has not been 
fully explored. Kawi’s project aimed to rem-
edy this using a two-pronged approach.
She first sought to identify variables, such 
as perceived support from health care provid-
ers, pain intensity, and functional ability, that 
might predict which low-back pain sufferers 
would respond best to self-management strat-
egies. Her second goal involved evaluating 
differences in those variables among patients 
seeking help in specialty pain centers and pri-
mary care clinics. Understanding these vari-
ables, she reasoned, could help maximize self-
management effectiveness in clinical settings, 
while enabling health care providers to tailor 
self-management strategies to fit the needs of 
individual patients.
Kawi and her team analyzed data from 230 
people with chronic low-back pain — 110 
from specialty pain centers and 120 from pri-
mary care clinics. Her research revealed five 
variables to be predictors of self-management 
for patients in both settings: age, self-manage-
ment support, education levels, overall health, 
and the helpfulness of pain management.
She also discovered differences among key 
variables in patients who sought care from a 
specialty pain center versus those who sought 
care in a primary care clinic. For example, 
participants in specialty pain centers were 
more apt to self-manage if they were active in 
their religious or spiritual beliefs or if they re-
ceived support from their significant others. 
On the other hand, low-back pain patients in 
primary care clinics who had higher incomes 
tended to self-manage more than those with 
lower incomes. These important preliminary 
findings have been tabbed for future research.
Kawi’s research has already provided es-
sential intervention data that health care pro-
viders can use to bolster the odds that chronic 
low-back pain patients will be able to success-
fully self-manage their conditions. The results 
also identified a need to formulate additional 
strategies for patients who may not be the best 
candidates for self-management programs. 
The study, which was funded by an exter-
nal grant from the Nurse Practitioner Health-





A PLAN FOR PAIN  UNLV’s Jennifer Kawi is helping both 
back-pain sufferers and their doctors embrace new 
ways of thinking about managing the condition. It’s 
an approach that promises to boost patient outcomes 
while reducing healthcare costs.
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Susan VanBeuge: 
For Ailing Seniors, 
Coordinated Solutions
PEOPLE OFTEN FACE MULTIPLE CHRONIC 
ailments during their senior years, clusters of 
conditions that demand a collaborative ap-
proach to treatment. But today there are few, if 
any, training opportunities aimed at preparing 
the next generation of practitioners and special-
ists for the challenges of providing the collab-
orative, interprofessional elder care that is so 
desperately needed.
Susan VanBeuge is changing that. 
VanBeuge is an assistant professor in the 
School of Nursing who is co-principal investiga-
tor with Georgia Dounis, an associate professor 
of clinical sciences in UNLV’s School of Dental 
Medicine, and Sue Schuerman, an assistant pro-
fessor in the School of Allied Health Sciences. 
The UNLV team is a sub-awardee of the Nevada 
Geriatric Education Consortium, a state-wide 
initiative aimed at improving the health care 
delivered to older adults.
The UNLV objectives include developing a 
Type 2 diabetes management training program 
for interprofessional faculty with emphasis on 
communication, prevention of co-morbidities, 
and cultural sensitivity.
At its core, VanBeuge’s program aims to de-
velop a series of provider training for senior 
health issues to include Type 2 diabetes and 
Alzheimer’s disease. The UNLV team, for exam-
ple, has developed a one-day training program 
focused on Type 2 diabetes and offered it state-
wide to health care providers and faculty who 
work with professional students. The program 
includes video-recorded encounters with “stan-
dardized” patients — individuals trained to sim-
ulate the needs of real patients — and hands-on 
training with high-fidelity manikins.
The program focused on Type 2 diabetes 
because of its multiple symptoms, prevalence 
among older adults, and the need for multiple 
health care professionals to involve them-
selves in treatment and management of the 
condition.
 During the training, each participant re-
ceived a chart detailing a standardized pa-
tient’s medical and social history, physical 
attributes, clinical findings, and chief com-
plaint. Teams had 15 minutes to complete 
the examination. During the encounter, each 
group assessed their patient’s physical status, 
formulated treatment goals and intervention 
options, noted potential outcomes, and iden-
tified opportunities for coordination of care. 
They also developed a plan for how responsi-
bility for that care would transpire.
The teams next participated in a debriefing 
session with the project’s instructors (who 
were observing the interactions in real time 
on video monitors). Finally, instructors led a 
group discussion and encouraged self-assess-
ments from participants.
Thus far, the five-year grant, now in its fourth 
year, has seen close to 100 participants complete 
the course. Early findings were published after 
the study’s second year. Participants at that time 
told the researchers that they had gained a bet-
ter understanding of inter-professional team 
building, a stronger ability to communicate ef-
fectively with team members, and greater confi-
dence in recognizing that meeting the needs of 
geriatric patients often requires an interprofes-
sional response.
The project has been featured in the Jour-
nal of Interdisciplinary Healthcare and has 
been presented during multiple national clin-
ical conferences. The team recently received 
additional funding to include Alzheimer’s dis-
ease and dementia to the course training for 
the coming year.
COLLABORATIVE CARE  Managing Type 2 diabetes 
and Alzheimer’s disease is one of senior care’s 
greatest challenges. UNLV’s Susan VanBeuge leads a 
team that is teaching a more coordinated approach.
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SCHOOL OF ALLIED HEALTH SCIENCES’ 
Steen Madsen is exploring new treatment 
methods for primary brain tumors — tu-
mors that originate in the brain — using 
nanoparticles and lasers. 
Madsen, professor and chair for the de-
partment of health physics and diagnostic 
sciences, is collaborating with Henry Hirsch-
berg, a researcher at the University of Cali-
fornia-Irvine’s Beckman Laser Institute and 
Medical Clinic, on a particularly promising 
approach. It involves using a type of white 
blood cell that ingests foreign material as a 
therapeutic-drug delivery vehicle. 
There are approximately 34,000 new cases 
of primary brain tumors diagnosed each year 
in the U.S. and Europe. Close to 40 percent 
of these tumors are of the most aggressively 
malignant variety, glioblastoma multiforme 
(GBM). Less than 5 percent of patients diag-
nosed with GBM will live more than five years. 
Glioblastoma tumors are notoriously aggres-
sive and difficult to treat. When removed dur-
ing surgery, they almost always reappear. Mad-
sen, Hirschberg, and their research team are 
exploring a small solution to this big problem: 
employing macrophages, the aforementioned, 
material-ingesting white blood cells, to trans-
port nano-sized particles of therapeutic gold to 
surgical resection sites. If successful, it’s a sys-
tem that could greatly enhance the effective-
ness of photothermal therapy, a process that 
destroys tumor cells using laser light. 
Why gold? The precious metal offers two 
particular advantages. First, it has already 
been used safely in humans for a variety 
of medical applications. Second, and more 
to the point, gold has the ability to convert 
infrared laser energy to thermal energy. 
When exposed to photothermal therapy, 
gold nanoparticles act as heat generators and 
burn the tumor cells.
In preliminary studies, Madsen and Hirsch-
berg demonstrated the feasibility of using mac-
rophages as delivery vehicles for gold-based 
nanoparticles. This was a particularly welcome 
finding given that, being part of the body’s 
natural defenses, macrophages can be easily ex-
tracted from a patient, loaded with the desired 
therapeutic agents and re-injected into the body.
During the study’s next phase, Madsen and 
Hirschberg’s team showed that using gold-
loaded macrophages in concert with photo-
thermal therapy was effective in treating tu-
mor cells in the brains of laboratory animals. 
Animals that received the macrophages and 
photothermal therapy, in fact, showed zero 
tumor cells when the treatments concluded. 
These findings and others have been pub-
lished in the Annals of Biomedical Engineer-
ing and Lasers in Surgery and Medicine.
Hurdles remain, however. Part of Madsen 
and Hirschberg’s current research involves 
searching for a means to allow nanoparticle-
loaded macrophages to pass through the 
body’s “blood-brain barrier,” the biological 
mechanism preventing most external cells 
and other matter from passing through to the 
brain. Thus far, the answer has eluded them.
Madsen and Hirschberg say they are confi-
dent that this obstacle, too, can be overcome, 
and that, once bypassed, they will be that 
much closer to improving the dismal five-year 
survival rate of GBM patients.  
Steen Madsen:  
A Nano-Sized Weapon 
Against Glioblastoma
MASTERING MACROPHAGES A new, nano-particle-
based drug delivery system being developed by 
UNLV’s Steen Madsen offers hope against primary 
brain tumors.
